The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart Failure: Results of a 1-Year, Prospective, Randomized, Placebo-Controlled Study
Open accessAbstract
Background—: In heart failure (HF), a defective nitric oxide signaling is involved in left ventricular (LV) diastolic abnormalities and remodeling. PDE5 inhibition, by blocking degradation of nitric oxide second-messenger cyclic guanosine monophosphate, might be beneficial. In a cohort of systolic HF patients, we tested the effects of PDE5 inhibition (sildenafil) on LV ejection fraction, diastolic function, cardiac geometry, and clinical status. Methods and Results—: Forty-five HF patients (New York Heart Association class II-III) were randomly assigned to placebo or sildenafil (50 mg three times per day) for 1 year, with assessment (6 months and 1 year) of LV ejection fraction, diastolic function, geometry, cardiopulmonary exercise performance, and quality of life. In the sildenafil group only, at 6 months and 1 year, LV ejection fraction, early diastolic tissue Doppler velocities (E′) at the mitral lateral (from 4.62 to 5.20 and 5.19 m/s) and septal (from 4.71 to 5.23 and 5.24 m/s) annuli significantly increased, whereas the ratio of early transmitral (E) to E′ lateral decreased (from 13.1 to 9.8 to 9.4) ( P <0.01). Changes were accompanied by a reverse remodeling of left atrial volume index (from 32.0 to 29.0 and 29.1 mL/m 2 ; P <0.01) and LV mass index (from 148.0 to 130.0 and 128.0 g/m 2 ; P <0.01). Furthermore, sildenafil improved exercise performance (peak V o 2 ), ventilation efficiency (ventilation to CO 2 production slope), and quality of life ( P <0.01). Minor adverse effects were noted: flushing in 4 and headache in 2 treated patients. Conclusions—: Findings confirm that in HF, sildenafil improves functional capacity and clinical status and provide the first human evidence that LV diastolic function and cardiac geometry are additional targets of benefits related to chronic PDE5 inhibition. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00975494.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Tarver, T. (2014) · Journal of Consumer Health On the Internet · doi:10.1080/15398285.2014.902284 · Cited by 5,605
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
Devereux, R. B., & Reichek, N. (1977) · Circulation · doi:10.1161/01.cir.55.4.613 · Cited by 4,485
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
Nagueh, S. F., Middleton, K. J., Kopelen, H. A., Zoghbi, W. A., & Quiñones, M. A. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00344-6 · Cited by 3,029
Quiñones, M. A., Otto, C. M., Stoddard, M., Waggoner, A., & Zoghbi, W. A. (2002) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2002.120202 · Cited by 2,130
Yock, P. G., & Popp, R. L. (1984) · Circulation · doi:10.1161/01.cir.70.4.657 · Cited by 1,640
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Takimoto, E., Champion, H. C., Li, M., Belardi, D., Ren, S., Rodriguez, E. R., Bedja, D., Gabrielson, K. L., Wang, Y., & Kass, D. A. (2005) · Nature Medicine · doi:10.1038/nm1175 · Cited by 903
Lewis, G. D., Shah, R., Shahzad, K., Camuso, J. M., Pappagianopoulos, P. P., Hung, J., Tawakol, A., Gerszten, R. E., Systrom, D. M., Bloch, K. D., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.716373 · Cited by 515
Balligand, J. L., Ungureanu, D., Kelly, R. A., Kobzik, L., Pimental, D., Michel, T., & Smith, T. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116461 · Cited by 453
Mullens, W., Borowski, A. G., Curtin, R. J., Thomas, J. D., & Tang, W. H. (2009) · Circulation · doi:10.1161/circulationaha.108.779223 · Cited by 444
Krüger, M., Kötter, S., Grützner, A., Lang, P., Andresen, C., Redfield, M. M., Butt, E., dos Remedios, C. G., & Linke, W. A. (2009) · Circulation Research · doi:10.1161/circresaha.108.184408 · Cited by 407
Paulus, W. J., Vantrimpont, P. J., & Shah, A. M. (1994) · Circulation · doi:10.1161/01.cir.89.5.2070 · Cited by 370
Fisher, P. W., Salloum, F., Das, A., Hyder, H., & Kukreja, R. C. (2005) · Circulation · doi:10.1161/01.cir.0000160359.49478.c2 · Cited by 355
Sildenafil Improves Exercise Hemodynamics and Oxygen Uptake in Patients With Systolic Heart Failure
Lewis, G. D., Lachmann, J., Camuso, J., Lepore, J. J., Shin, J., Martinovic, M. E., Systrom, D. M., Bloch, K. D., & Semigran, M. J. (2007) · Circulation · doi:10.1161/circulationaha.106.626226 · Cited by 353
Unlocking the Mysteries of Diastolic Function
Lester, S. J., Tajik, A. J., Nishimura, R. A., Oh, J. K., Khandheria, B. K., & Seward, J. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.061 · Cited by 350
Giannuzzi, P., Temporelli, P. L., Corrà, U., & Tavazzi, L. (2003) · Circulation · doi:10.1161/01.cir.0000081780.38477.fa · Cited by 342
Development and testing of a new measure of health status for clinical trials in heart failure
Guyatt, G. H., Nogradi, S., Halcrow, S., Singer, J., Sullivan, M. J. J., & Fallen, E. L. (1989) · Journal of General Internal Medicine · doi:10.1007/bf02602348 · Cited by 335
Long-Term Use of Sildenafil in the Therapeutic Management of Heart Failure
Guazzi, M., Samaja, M., Arena, R., Vicenzi, M., & Guazzi, M. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.078 · Cited by 323
Self-citationRecchia, F. A., McConnell, P. I., Bernstein, R. D., Vogel, T. R., Xu, X., & Hintze, T. H. (1998) · Circulation Research · doi:10.1161/01.res.83.10.969 · Cited by 302 · cited 1×
“E/E’, a variable repeatedly found related to left ventricular filling pressures in a variety of leftsided cardiac disorders (26,27), significantly decreased at 6 months and 1 year of active treatment.”
Guazzi, M., Tumminello, G., Di Marco, F., Fiorentini, C., & Guazzi, M. D. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.041 · Cited by 222
Self-citationPhosphodiesterase Type 5: Expanding Roles in Cardiovascular Regulation
Kass, D. A., Champion, H. C., & Beavo, J. A. (2007) · Circulation Research · doi:10.1161/circresaha.107.162511 · Cited by 217
Lepore, J. J., Maroo, A., Bigatello, L. M., Dec, G. W., Zapol, W. M., Bloch, K. D., & Semigran, M. J. (2005) · Chest · doi:10.1378/chest.127.5.1647 · Cited by 195
Pokreisz, P., Vandenwijngaert, S., Bito, V., Van den Bergh, A., Lenaerts, I., Busch, C., Marsboom, G., Gheysens, O., Vermeersch, P., Biesmans, L., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.822072 · Cited by 185
PDE5A Inhibitor Treatment of Persistent Pulmonary Hypertension After Mechanical Circulatory Support
Tedford, R. J., Hemnes, A. R., Russell, S. D., Wittstein, I. S., Mahmud, M., Zaiman, A. L., Mathai, S. C., Thiemann, D. R., Hassoun, P. M., Girgis, R. E., et al. (2008) · Circulation: Heart Failure · doi:10.1161/circheartfailure.108.796789 · Cited by 185
Asghar, O., Alsunni, A. A., Khavandi, K., Khavandi, A., Withers, S., Greenstein, A. S., Heagerty, A. M., & Malik, R. A. (2009) · Clinical Science · doi:10.1042/cs20080500 · Cited by 185
Rivas-Gotz, C., Khoury, D. S., Manolios, M., Rao, L., Kopelen, H. A., & Nagueh, S. F. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)01034-9 · Cited by 179
Sildenafil Inhibits β-Adrenergic–Stimulated Cardiac Contractility in Humans
Borlaug, B. A., Melenovsky, V., Marhin, T., Fitzgerald, P., & Kass, D. A. (2005) · Circulation · doi:10.1161/circulationaha.105.540500 · Cited by 169
Nagayama, T., Hsu, S., Zhang, M., Koitabashi, N., Bedja, D., Gabrielson, K. L., Takimoto, E., & Kass, D. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.069 · Cited by 164
Compartmentalization of Cardiac β-Adrenergic Inotropy Modulation by Phosphodiesterase Type 5
Takimoto, E., Belardi, D. F., Tocchetti, C. G., Vahebi, S., Cormaci, G., Ketner, E., Moens, A. L., Champion, H. C., & Kass, D. A. (2007) · Circulation · doi:10.1161/circulationaha.106.643536 · Cited by 154
Behling, A., Rohde, L. E. P., Colombo, F., Goldraich, L. A., Stein, R., & Clausell, N. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.11.006 · Cited by 127
Salloum, F. N., Ockaili, R. A., Wittkamp, M., Marwaha, V. R., & Kukreja, R. C. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.10.002 · Cited by 100
Webster, L., Michelakis, E. D., Davis, T. M. A., & Archer, S. L. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.5.514 · Cited by 90
Nitric oxide's role in the heart: control of beating or breathing?
Paulus, W. J., & Bronzwaer, J. G. F. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01147.2003 · Cited by 82
Nitric oxide signaling in the cardiovascular system: implications for heart failure
Saraiva, R. M., & Hare, J. M. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000221584.56372.dc · Cited by 74
Clinical Use of Phosphodiesterase-5 Inhibitors in Chronic Heart Failure
Guazzi, M. (2008) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.802116 · Cited by 64
Self-citationMagnoni, M., Esposito, A., Coli, S., Scuteri, L., COBELLI, F. D., Cianflone, D., Maschio, A. D., & Maseri, A. (2010) · Circulation · doi:10.1161/circulationaha.109.878314 · Cited by 61
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Self-citationESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Metadata
- Authors
- Guazzi, M., Vicenzi, M., Arena, R., & Guazzi, M. D.
- Venue
- Circulation: Heart Failure
- Published
- 2011-01
- Volume
- 4
- Issue
- 1
- Pages
- 8-17
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2117239217
- Cited by
- 382
- References
- 37
- FWCI
- 22.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.